J Drug Deliv Sci Technol 32:66–76 Tosi G et al (2016) The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system.
J Drug Deliv Sci Technol 32:66–76 Tucker EJ (2022) The genetics and biology of FOXL2.
| Precaution | Rationale | Recommendations |
|---|---|---|
| Avoid Driving or Operating Machinery | Dizziness and drowsiness risk | Do not drive or operate tools until effects wear off |
| Inform Doctor of Medical History | Potential drug interactions or contraindications | Especially liver disease, heart issues |
| Do not combine with Alcohol | Increase adverse effect risk | Avoid alcohol during treatment |
Sex Dev 16(2–3):184–193 Tucker EJ (2022) The genetics and biology of FOXL2.
| Parameter | Description | Typical Values |
|---|---|---|
| Absorption Rate | Time to reach peak plasma levels | ~1.5 hours |
| Bioavailability | Percentage of dose reaching systemic circulation | ~42% |
| Half-life | Time for plasma concentration to reduce by half | ~20 hours |
| Metabolism | Liver processing via CYP2D6 and CYP3A4 | CYP enzymes involved |
Sex Dev 16(2–3):184–193 Waldinger, M et al (2006) A multi-national population survey of intravaginal ejaculation latency time.
J Sex Marital Ther 12(4):267–281 Olivier B, Van Oorschot R, Waldinger M (1998) Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Olivier B, Van Oorschot R, Waldinger M (1998) Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Olivier JD et al (2023) A new approach to ‘on-demand’treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats. Pattij T, Olivier B, Waldinger M (2005a) Animal models of ejaculatory behavior. Curr Pharm Des 11(31):4069–4077 Pattij T, Olivier B, Waldinger M (2005a) Animal models of ejaculatory behavior.
Curr Pharm Des 11(31):4069–4077 Pattij T et al (2005b) Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. Eur J Neurosci 22(3):724–734 Pattij T et al (2005b) Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. Eur J Neurosci 22(3):724–734 Peugh J, Belenko S (2001) Alcohol, drugs and sexual function: a review. J Psychoact Drugs 33(3):223–232 Peugh J, Belenko S (2001) Alcohol, drugs and sexual function: a review. J Psychoact Drugs 33(3):223–232 Porst H et al (2007) The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. SOC SCIENTIFIC STUDY SEX INC PO BOX 208, MT VERNON, IA 52314 USA. Waldinger, M et al (2006) A multi-national population survey of intravaginal ejaculation latency time.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Priligy Generic Dapoxetine | 60mg | 60 + 8 Pills | 183.06€ 174.34€ | |
| Kamagra Soft Tabs | 100 mg | 84 + 4 Pills | 233.05€ 221.95€ | |
| Priligy Generic Dapoxetine | 60mg | 180 + 10 Pills | 494.76€ 471.20€ | |
| Priligy Generic Dapoxetine | 60mg | 120 + 10 Pills | 341.26€ 325.01€ | |
| Cialis Professional | 20mg | 180 + 4 Pills | 423.11€ 402.96€ | |
| Priligy Generic Dapoxetine | 60mg | 30 + 6 Pills | 106.65€ 101.57€ | |
| Cialis Generic | 2.5mg | 30 + 4 Pills | 51.95€ 49.48€ | |
| Priligy Generic Dapoxetine | 60mg | 10 Pills | 47.63€ 45.36€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ | |
| Cialis Generic | 20mg | 60 + 6 Pills | 117.76€ 112.15€ | |
| Cialis Generic | 10mg | 120 + 6 Pills | 178.49€ 169.99€ | |
| Priligy Generic Dapoxetine | 60mg | 20 + 4 Pills | 77.31€ 73.63€ |
Waldinger M et al (1998) Familial occurrence of primary premature ejaculation.
Int J Impot Res 16(4):369–381 Wissing S, Müller R (2002) Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 81(3):225–233 Wissing S, Müller R (2002) Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration.
Porst H et al (2007) The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Int J Pharm 143(2):133–141 Reading AE, Wiest WM (1984) An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav 13(1):69–83 Reading AE, Wiest WM (1984) An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav 13(1):69–83 Salem HF et al (2020a) Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCl amalgamated as a nanoplatform: in vitro and in vivo assessment. Salem HF et al (2020a) Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCl amalgamated as a nanoplatform: in vitro and in vivo assessment.
Salem HF et al (2020b) Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCl amalgamated as a nanoplatform: in vitro and in vivo assessment. Salem HF et al (2020c) Novel enhanced therapeutic efficacy of dapoxetine HCl by nano-vesicle transdermal gel for treatment of carrageenan-induced rat paw edema. Schapiro B (1943) Premature ejaculation: a review of 1130 cases. Screponi E et al (2001) Prevalence of chronic prostatitis in men with premature ejaculation. Seju U, Kumar A, Sawant K (2011) Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro tadalafil with dapoxetine online and in vivo studies. J Control Release 81(3):225–233 Wissing SA, Müller RH (2003) Cosmetic applications for solid lipid nanoparticles (SLN).
| Interaction | Effect | Advice |
|---|---|---|
| SSRIs | Increased risk of side effects | Consult doctor before combining |
| CYP3A4 Inhibitors | Elevated dapoxetine levels | Dose adjustment recommended |
| Alcohol | Increased dizziness, risk of side effects | Avoid alcohol during treatment |
Int J Pharm 254(1):65–68 Wissing SA, Müller RH (2003) Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 254(1):65–68 Wu Y et al (2005) Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
Int J Pharm 295(1–2):235–245 Wu Y et al (2005) Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 295(1–2):235–245 Yang Y-Y, Chung T-S, Ng NP (2001) Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Yang Y-Y, Chung T-S, Ng NP (2001) Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
Br J Med Psychol 59(4):351–358 Spector KR, Boyle M (1986) The prevalence and perceived aetiology of male sexual problems in a non-clinical sample. Br J Med Psychol 59(4):351–358 Spector IP, Carey MP (1990) Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 19(4):389–408 Spector IP, Carey MP (1990) Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 19(4):389–408 Symonds T et al (2003) How does premature ejaculation impact a man’s life? J Sex Marital Ther 29(5):361–370 Symonds T et al (2003) How does premature ejaculation impact a man’s life?
J Sex Marital Ther 29(5):361–370 Teeranachaideekul V et al (2008) Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 128(2):134–141 Teeranachaideekul V et al (2008) Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 128(2):134–141 Tengamnuay P et al (2000) Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 197(1–2):53–67 Tengamnuay P et al (2000) Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 197(1–2):53–67 Tosi G et al (2016) The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system. Yokosuka M et al (2001) The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis. Zaki NM et al (2007) Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32(4–5):296–307 Zaki NM et al (2007) Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32(4–5):296–307 Zambaux M (1998) Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method.
Semans JH (1956) Premature ejaculation: a new approach. Shalaby A, Shaker GA, El-Adawy EH (2018) Paricalcitrol role on erectile function and penile NOS expression in diabetic rats. Sharma D et al (2014) Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Sharma N, Madan P, Lin S (2016) Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci 11(3):404–416 Sharma N, Madan P, Lin S (2016) Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study.
Asian J Pharm Sci 11(3):404–416 Smith ER, Davidson JM (1990) Yohimbine attenuates aging-induced sexual deficiencies in male rats. Smith ER, Davidson JM (1990) Yohimbine attenuates aging-induced sexual deficiencies in male rats. Snedecor G, Cochran W (1982) Statistical Methods, vol 507, 7th Edit., 2nd printing. Press, Ames, IWA, USA, pp 53–57 Snedecor G, Cochran W (1982) Statistical Methods, vol 507, 7th Edit., 2nd printing. Press, Ames, IWA, USA, pp 53–57 Spector KR, Boyle M (1986) The prevalence and perceived aetiology of male sexual problems in a non-clinical sample. J Control Release 50(1–3):31–40 Zambaux M (1998) Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method.
Eur J Pharm Sci 48(3):393–405 Md S et al (2013) Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci 48(3):393–405 Metz E, Michael JLP (2000) Premature ejaculation: a psychophysiological approach for assessment and management. J Sex Marital Ther 26(4):293–320 Metz E, Michael JLP (2000) Premature ejaculation: a psychophysiological approach for assessment and management. J Sex Marital Ther 26(4):293–320 Misra A et al (2003) Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 6(2):252–273 Misra A et al (2003) Drug delivery to the central nervous system: a review.
J Pharm Pharm Sci 6(2):252–273 Nagarajan E et al (2015) Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole. J Appl Pharm Sci 5(04):020–025 Nagarajan E et al (2015) Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole. Nasr M et al (2008) Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. Nathan SG (1986) The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther 12(4):267–281 Nathan SG (1986) The epidemiology of the DSM-III psychosexual dysfunctions.